Navigation Links
Robert Lowen MD, Expert Bay Area Plastic Surgeon, Announces Cutting-Edge 3-D Crisalix Imaging Technology to Aid Patients in Choosing their Breast Implant Size
Date:4/26/2013

Mountain View, CA (PRWEB) April 26, 2013

Dr. Lowen has been in the private practice of plastic surgery for 25 years. Trained at Stanford and the University of Colorado, he is board-certified by the American Board of Plastic Surgery, and a member of the American Society for Aesthetic Plastic Surgery. He specializes in cosmetic surgery of the face, breast and body, and is well-known for his attention to detail and excellent results.

When someone thinks about modifying their physical aspect, seeing the outcome beforehand is essential. Already for a simple act of choosing new clothes, one is used to trying on before buying. It is therefore understandable that only once a person has seen a 3D simulation answering the question “how could I look after the procedure?” that they can properly imagine and understand the change they are contemplating.

Crisalix is the world’s first web-based 3D simulator for aesthetic procedures, which recreates in 3D the patient’s face or body using three standard 2D photos that the patient uploaded from the comfort of their home. The 3D images are generated by Crisalix and sent to the doctor before the patient even comes to the clinic to enable accurate pre-visualizations of the final result of the procedure during the consultation.

The surgeon can concentrate exclusively on understanding and clarifying the patient’s desires and expectations, without spending precious time taking photos or preparing the 3D images. The patient can actively participate in the process of generating the 3D images and seeing their new face or body in 3D, as opposed to imagining the result using traditional methods, such as photos of other patients that do not represent the patient’s own anatomy.

This breakthrough technology, now offered by Dr. Lowen, increases patient education, understanding and interaction, to further optimize in-consultation and post-procedure satisfaction.

What do patients and the world’s top plastic surgeons say about Crisalix?

A recent study carried out in Switzerland on patients who had breast augmentation between 2011 and 2012 and who saw Crisalix 3D simulations of their new body during pre-surgery consultations showed that 87.5% felt Crisalix allowed them to express their desires and expectations and all were either satisfied or very satisfied with the 3D images.

“This is a fantastic revolution for the patient as well as for the surgeon. For the patient, there is nothing like seeing simulations of her own body. This technology should help all surgeons, from novice to advanced, in establishing realistic patient expectations and improving results." - Prof. Jan Poell, Plastic Surgeon, former President of the International Society of Aesthetic Plastic Surgery

Crisalix’s technology is recommended by the world’s leading federation in this field.

IPRAS, the leading international federation for Plastic Surgery, recommends Crisalix (http://www.crisalix.com) for the significant progress its 3D simulation technology brings to the entire medical community, along with its contribution to patient education and a more informed decision-making process. Patients using Crisalix have demonstrated much higher levels of satisfaction, corresponding directly to IPRAS’ objectives in improving the care and treatment of every patient seeking plastic surgery.

Read the full story at http://www.prweb.com/releases/drlowen/crisalix3d/prweb10666030.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
2. Robert Farrell Joins Bionovos Board of Directors
3. Engineer Robert J. Wood to receive NSFs Alan T. Waterman Award
4. Fortis Vice President of Nursing Robert Anders Named Academy of Nursing Education Fellow by National League for Nursing
5. Robert Kirsner, MD, PhD, To Present Results For Phase 2b 6-Month Follow-Up Trial Of Unique Investigational Cell-Based Therapy For Venous Leg Ulcers
6. Robert Haynes To Lead Licensing As VR Laboratories Senior Vice President Product Introduction And Licensing
7. Pittcon Announces 2013 Award Recipients; New Award, Robert Boyle Prize for Analytical Science, Added to Technical Program
8. Robert Storey Joins VIC Technology Venture Development as Executive in Residence
9. Roberto DellOro Named Director of LMUs Bioethics Institute
10. Entertainment Agency and Speaker Bureau Mark Sonder Productions Signs the Health & Wellness Shaman, Robert Cohen, PhD, LPC, DCEP for Meetings and Events Worldwide
11. Dr. J. Robert Beyster and Betty J. Beyster Make $2.5 Million Pledge to the J. Craig Venter Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... ... 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), a ... webinar on Performing Quality Investigations: Getting to Root Cause. This ... charge. , Incomplete investigations are still a major concern to the Regulatory Authorities ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
Breaking Biology Technology:
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):